Mirae Asset Global ETFs Holdings
JSPR icon

Mirae Asset Global ETFs Holdings’s Jasper Therapeutics JSPR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-6,828
Closed -$29.4K – 3125
2025
Q1 		$29.4K Buy
6,828
+312
+5% +$2.08K ﹤0.01% 2931
2024
Q4 		$139K Buy
6,516
+304
+5% +$6.33K ﹤0.01% 2559
2024
Q3 		$117K Buy
+6,212
New +$124K ﹤0.01% 2645

Other funds holding JSPR

Soleus Capital Management
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return
Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Integral Health Asset Management
Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's JSPR Position: Q2 2025 in Review

Mirae Asset Global ETFs Holdings sold out of Jasper Therapeutics (JSPR) in Q2 2025, closing a stake of 6,828 shares — an estimated $29.4K sold.

Mirae Asset Global ETFs Holdings first reported a position in JSPR in Q3 2024 and held it in 3 quarters. The position peaked at $139K in Q4 2024. 65 funds tracked by Wall St. Rank hold JSPR as of Q2 2025.

  • Mirae Asset Global ETFs Holdings reported no remaining Jasper Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Mirae Asset Global ETFs Holdings sold 6,828 Jasper Therapeutics shares in Q2 2025, an estimated $29.4K.
  • Mirae Asset Global ETFs Holdings first reported a position in Jasper Therapeutics in Q3 2024 and held it in 3 quarters.
  • Mirae Asset Global ETFs Holdings's Jasper Therapeutics position peaked at $139K in Q4 2024.
  • 65 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2025.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.